HOLX

Hologic Inc

HOLX, USA

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analysis software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology systems; and breast conserving surgery products. In addition, the company provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system. The company sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

https://www.hologic.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
HOLX
stock
HOLX

Hologic (HOLX): Evaluating Valuation After a Steady 3-Month Share Price Climb simplywall.st

Read more →
HOLX
stock
HOLX

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know Yahoo Finance

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$76.5

Analyst Picks

Strong Buy

3

Buy

3

Hold

14

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Medium

30.11

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

3.50

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

3.87 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

2.13 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

30.94 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Low

0.82

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 101.36% of the total shares of Hologic Inc

1.

Vanguard Group Inc

(12.0501%)

since

2025/06/30

2.

T. Rowe Price Investment Management,Inc.

(10.8279%)

since

2025/06/30

3.

BlackRock Inc

(8.9657%)

since

2025/06/30

4.

Manufacturers Life Insurance Co

(4.9557%)

since

2025/06/30

5.

State Street Corp

(4.5405%)

since

2025/06/30

6.

T. Rowe Price US Mid-Cap Growth Equity

(4.0427%)

since

2025/06/30

7.

T. Rowe Price Mid-Cap Growth

(4.0354%)

since

2025/07/31

8.

Amvescap Plc.

(3.75%)

since

2025/06/30

9.

Vanguard Total Stock Mkt Idx Inv

(3.1523%)

since

2025/07/31

10.

T. Rowe Price Capital Appreciation

(3.0363%)

since

2025/07/31

11.

Geode Capital Management, LLC

(2.6204%)

since

2025/06/30

12.

Vanguard 500 Index Investor

(2.4809%)

since

2025/07/31

13.

Victory Capital Management Inc.

(2.4723%)

since

2025/06/30

14.

Vanguard Small Cap Index

(2.4324%)

since

2025/07/31

15.

Black Creek Investment Management Inc

(1.8109%)

since

2025/06/30

16.

Victory Sycamore Established Value R

(1.7809%)

since

2025/06/30

17.

MS INVF Global Brands A

(1.6905%)

since

2025/03/31

18.

Citadel Advisors Llc

(1.6675%)

since

2025/06/30

19.

Vanguard Small Cap Value Index Inv

(1.5658%)

since

2025/07/31

20.

Bank of America Corp

(1.3894%)

since

2025/06/30

21.

Northern Trust Corp

(1.2741%)

since

2025/06/30

22.

Fidelity 500 Index

(1.27%)

since

2025/07/31

23.

T. Rowe Price U.S. Mid-Cap Gr Eq Tr-D

(1.2654%)

since

2025/06/30

24.

Arrowstreet Capital Limited Partnership

(1.2444%)

since

2025/06/30

25.

NORGES BANK

(1.2424%)

since

2025/06/30

26.

CI Global Leaders Fund D

(1.2353%)

since

2025/08/31

27.

SPDR® S&P 500® ETF

(1.219%)

since

2025/08/31

28.

iShares Core S&P 500 ETF

(1.2059%)

since

2025/08/31

29.

JHancock Fundamental Large Cap Core A

(1.1951%)

since

2025/07/31

30.

UBS Asset Mgmt Americas Inc

(1.1666%)

since

2025/06/30

31.

Nordea Investment Mgmt Bank Demark A/s

(1.1633%)

since

2025/06/30

32.

Manulife IM US Large Cap Core

(1.1533%)

since

2025/06/30

33.

Dimensional Fund Advisors, Inc.

(1.1329%)

since

2025/06/30

34.

Morgan Stanley - Brokerage Accounts

(1.0611%)

since

2025/06/30

35.

AllianceBernstein L.P.

(1.0074%)

since

2025/06/30

36.

Invesco S&P 500® Equal Weight ETF

(0.9847%)

since

2025/08/29

37.

Invesco Small Cap Value A

(0.9768%)

since

2025/07/31

38.

Ameriprise Financial Inc

(0.873%)

since

2025/06/30

39.

Invesco Value Opportunities A

(0.7165%)

since

2025/07/31

40.

Allspring Special Mid Cap Value Inst

(0.7088%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

1.13

EPS Estimate

1.1

EPS Difference

0.03

Surprise Percent

2.7273%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(7.3)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(3)
Momentum
Moderate Momentum(6)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
High Quality(7.5)
Value
Fair Value(4.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.